Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma
Hamid, Omid, Puzanov, Igor, Dummer, Reinhard, Schachter, Jacob, Daud, Adil, Schadendorf, Dirk, Blank, Christian, Cranmer, Lee D., Robert, Caroline, Pavlick, Anna C., Gonzalez, Rene, Hodi, F. Stephen,Volume:
86
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2017.07.022
Date:
November, 2017
File:
PDF, 760 KB
english, 2017